Login or sign up
For business

Novatio ventures

3.9· 9 reviews
Average ratingAverage
3.9/ 5

Based on 9 reviews

533%
422%
344%
20%
10%
Ask AI

Ask AI about Novatio ventures

Generated with AI from 9 reviews on Trustburn

AI-generated from reviews on this page. Verify anything important with the company directly.

News

No news yet. This is where the business shares its own updates and press.

Photos

No photos yet. Photos shared by reviewers will show up here.

Widgets

Boost your business trust by displaying a widget on your website — a simple way to convert your visitors into customers.

Get the widget for your site →

About Novatio ventures

Novatio Ventures is a venture capital firm accelerating the commercialization of life science innovations.

The firm's focus is on the development of innovations and other markets that represents a significant source of opportunities for outsized value creation. It invests in firms operating in therapeutics, diagnostics, devices, and drug delivery technologies. They target early-stage innovation on the transition of preclinical proof-of-concept or validation and provides seed funding and work actively with inventors, entrepreneurs, and institutions to devise and implement development and commercialization strategies, assemble management teams, and secure additional capital. It aims to leverage their collective experience and industry network to achieve early exits that generate attractive, risk-mitigated financial returns.

Peng Fu established the firm in Toronto, Ontario in 2015.

Address
100 king street west